Fibroblast growth factor 23 and bone mineralisation

被引：0
作者：
Yu-Chen Guo
Quan Yuan
机构：
[1] State Key Laboratory of Oral Diseases,
[2] West China Hospital of Stomatology,undefined
[3] Sichuan University,undefined
[4] Chengdu,undefined
[5] China,undefined
来源：
International Journal of Oral Science | 2015年 / 7卷
关键词：
bone mineralisation; chronic kidney disease; fibroblast growth factor 23;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Fibroblast growth factor 23 (FGF23) is a hormone that is mainly secreted by osteocytes and osteoblasts in bone. The critical role of FGF23 in mineral ion homeostasis was first identified in human genetic and acquired rachitic diseases and has been further characterised in animal models. Recent studies have revealed that the levels of FGF23 increase significantly at the very early stages of chronic kidney disease (CKD) and may play a critical role in mineral ion disorders and bone metabolism in these patients. Our recent publications have also shown that FGF23 and its cofactor, Klotho, may play an independent role in directly regulating bone mineralisation instead of producing a systematic effect. In this review, we will discuss the new role of FGF23 in bone mineralisation and the pathophysiology of CKD-related bone disorders.
引用
收藏
页码：8 / 13
页数：5
相关论文
共 303 条
  • [1] Shimada T(2004)Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J Clin Invest 113 561-568
  • [2] Kakitani M(2004)Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice Matrix Biol 23 421-432
  • [3] Yamazaki Y(2010)Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23 Annu Rev Med 61 91-104
  • [4] Sitara D(2000)Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat Genet 26 345-348
  • [5] Razzaque MS(2001)Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia Proc Natl Acad Sci U S A 98 6500-6505
  • [6] Hesse M(2007)FGF23 is a hormone-regulating phosphate metabolism–unique biological characteristics of FGF23 Bone 40 1190-1195
  • [7] Bergwitz C(2006)The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis J Clin Endocrinol Metab 91 4037-4042
  • [8] Jüppner H(2007)Determination of the elimination half-life of fibroblast growth factor-23 J Clin Endocrinol Metab 92 2374-2377
  • [9] Shimada T(2004)Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia J Clin Endocrinol Metab 89 3979-3982
  • [10] Mizutani S(2004)FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa Biochem Biophys Res Commun 314 409-414
12345678910